Pulmonary clearance of vasoactive intestinal peptide.

Vasoactive intestinal peptide causes bronchodilatation when given intravenously but is less effective in both animals and man when given by inhalation. This difference may be due to poor transit of the peptide across the bronchial epithelium. To test this hypothesis pulmonary clearance of radiolabel...

Descrición completa

Detalles Bibliográficos

Publicado en:	Thorax
Principais autores:	Barrowcliffe, M P, Morice, A, Jones, J G, Sever, P S
Formato:	Artigo
Idioma:	Inglês
Publicado:	BMJ Publishing Group 1986
Assuntos:	Research Article
Acceso en liña:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC460268/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3010486/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/thx.41.2.88
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!